GIP and GLP-1 co-agonist compounds

TT202600026BActive Publication Date: 2026-08-12ELI LILLY & CO

0 Cites 0 Cited by

Patent Information

Application Number: TT202200008
Authority / Receiving Office: TT · TT
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2016-01-05
Publication Date: 2026-08-12
Estimated Expiration: 2036-01-05

Application Information

Patent Timeline

05 Jan 2016

Application

TT202200008

12 Aug 2026

Publication

TT202600026B

Inventors: ALSINA-FERNANDEZ, Jorge; BOKVIST, Bengt, Krister

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to dual incretin peptide mimetic compounds that agonize receptors for both human glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), and may be useful for treating type 2 diabetes mellitus (T2D).

Need to check novelty before this filing date? Find Prior Art